+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID05802836

Observing Changes in Anti-factor VIII Antibodies During Emicizumab Treatment in Patients with Severe Hemophilia A

Led by Christoph Königs · Updated on 2023-07-10

100

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to understand how antibodies and inhibitors against coagulation factor VIII change over time in patients with severe hemophilia A who are receiving emicizumab treatment. The study focuses on patients with or without factor VIII inhibitors and investigates their antibody responses and inhibitor development or disappearance over three years. It is an observational study led by Christoph Knigs, without additional interventions beyond routine care. Participants are grouped based on their factor VIII inhibitor status and factor VIII therapy use those without inhibitors receiving factor VIII therapy on demand or regularly, those with inhibitors receiving regular factor VIII therapy immune tolerance induction, and those with inhibitors not receiving factor VIII therapy. The study does not involve new treatments or procedures but monitors these patient groups during their ongoing emicizumab therapy. Participants continue their regular medical care with no extra visits or procedures required. Researchers analyze leftover samples from routine visits to monitor the development or disappearance of factor VIII inhibitors and antibodies over three years. They also assess treatment responses to bleeding episodes and characterize antibody quality, including specific epitopes and IgG subclasses. The study aims to gather detailed information while minimizing impact on participants usual care routines.

CONDITIONS

Brief Title

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Research Team

S

Stephan Schultze-Strasser, Dr.

C

Christoph Koenigs, PD Dr. Dr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here